Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-23-005906

General Counsel sold 848 shares at $11.78 ($9,989)

  • General Counsel acquired 1,924 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ring Christine General Counsel 2023-01-30 Option exercise +1,924 8,109 D: show line 1 in the form
Ring Christine General Counsel 2023-01-30 Sale −848 $11.78 $9,989 7,261 D: show line 2 in the form
Open-market sales · 848 sh · avg $11.78 · $9,989

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ring Christine General Counsel 2023-01-30 Option exercise · Restricted Stock Units −1,924 23,089 D: show line 3 in the form
Loading xslF345X03/doc4.xml…